These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 10810436)

  • 1. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rational evaluation of different lymph node dissection].
    Chen JQ; Wang SB; Qi CL
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
    Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
    Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
    Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
    Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
    Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
    Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of extensive lymph node dissection on the survival of early gastric cancer.
    Ohgaki M; Toshio T; Akeo H; Yamasaki J; Togawa T
    Hepatogastroenterology; 1999; 46(27):2096-9. PubMed ID: 10430404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network.
    Verlato G; Roviello F; Marchet A; Giacopuzzi S; Marrelli D; Nitti D; de Manzoni G
    Ann Surg Oncol; 2009 Mar; 16(3):594-602. PubMed ID: 19118437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
    Schmid A; Thybusch A; Kremer B; Henne-Bruns D
    Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
    Reis E; Kama NA; Doganay M; Atli M; Dolapci M
    Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
    Sun D; Gong R; Wu H
    Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
    Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
    Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.